Grants > Evaluation of Centrally Infused Muscarinic Agonist Drugs Primates
Updated On: Jan. 19, 2025
Alzheimer's Disease Research Grant
Evaluation of Centrally Infused Muscarinic Agonist Drugs Primates
About the Research Project
Program
Alzheimer's Disease Research
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 1987 - March 31, 1989
Grant ID
A1986026
Grants
Related Grants
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Alzheimer's Disease Research
Evaluation of Centrally Infused Muscarinic Agonist Drugs in Primates
Active Dates
April 01, 1986 - March 31, 1987
Principal Investigator
Robert Harbaugh, MD
Evaluation of Centrally Infused Muscarinic Agonist Drugs in Primates
Active Dates
April 01, 1986 - March 31, 1987
Principal Investigator
Robert Harbaugh, MD